There are no significant Insider Shareholders in Monte Rosa Therapeutics as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Scott D Sandell | 7,692,298 | 30 Jun, 2021 | |
| Forest Baskett | 7,692,298 | 30 Jun, 2021 | |
| Liza Landsman | 7,692,298 | 30 Jun, 2021 | |
| Peter W. Sonsini | 7,692,298 | 30 Jun, 2021 | |
| Anthony A. Jr. Florence | 7,692,298 | 30 Jun, 2021 | |
| Joshua Makower | 7,692,298 | 30 Jun, 2021 | |
| Ali Behbahani | 7,692,298 | 30 Jun, 2021 | |
| Paul Edward Walker | 7,692,298 | 30 Jun, 2021 | |
| Mohamad Makhzoumi | 7,692,298 | 30 Jun, 2021 | |
| Carmen Chang | 7,692,298 | 30 Jun, 2021 | |
| Edward T Mathers | 7,692,298 | 30 Jun, 2021 | |
| Enterprise Associates 17, L.P. New | 7,692,298 | 30 Jun, 2021 | |
| Rick Yang | 7,692,298 | 30 Jun, 2021 | |
| Venture Capital Vi, L.P. Versant | 5,652,922 | 30 Oct, 2024 | |
| Asset Management, Lp Cormorant | 3,202,200 | 30 Jun, 2021 | |
| Bradley J Phd Bolzon | 2,097,938 | 30 Jun, 2021 | |
| Markus Warmuth | President & CEO | 544,538 | 06 Jan, 2025 |
| Filip Janku | Chief Medical Officer | 45,189 | 06 Jan, 2025 |
| Sharon Townson | Chief Scientific Officer | 36,000 | 06 Jan, 2025 |
| Philip Nickson | Chief Business & Legal Officer | 36,000 | 06 Jan, 2025 |
| Jennifer Champoux | Chief Operating Officer | 30,000 | 06 Jan, 2025 |
| Edmund Dunn | Principal Accounting Officer | 23,732 | 04 Jun, 2025 |
| Chandra P. Leo | 10,000 | 25 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Jun, 2025 | Edmund Dunn | Common Stock | D | 2,062 | $4.45 | 23,732 | D | S |
| 24 Mar, 2025 | Chandra P. Leo | Common Stock | A | 10,000 | $5.84 | 10,000 | D | P |
| 24 Mar, 2025 | Chandra P. Leo | - | - | 10,000 | D | |||
| 02 Jan, 2025 | Philip Nickson | Common Stock | A | 36,000 | - | 36,000 | D | A |
| 02 Jan, 2025 | Markus Warmuth | - | - | 544,538 | D | |||
| 02 Jan, 2025 | Filip Janku | Common Stock | A | 36,000 | - | 45,189 | D | A |
| 02 Jan, 2025 | Sharon Townson | Common Stock | A | 36,000 | - | 36,000 | D | A |
| 02 Jan, 2025 | Markus Warmuth | Common Stock | A | 128,000 | - | 544,538 | D | A |
| 02 Jan, 2025 | Jennifer Champoux | Common Stock | A | 30,000 | - | 30,000 | D | A |
| 02 Jan, 2025 | Edmund Dunn | Common Stock | A | 11,850 | - | 25,794 | D | A |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | Common Stock | D | 89,990 | $9.66 | 2,007,948 | I | S |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | - | - | 2,007,948 | I | |||
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | Common Stock | D | 1,019,867 | $0.00 | 4,079,469 | D | J |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | - | - | 4,079,469 | D | |||
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | - | - | 20,397 | I | |||
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | Common Stock | A | 20,397 | $0.00 | 20,397 | I | J |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | Common Stock | D | 20,397 | $0.00 | 0 | I | J |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | - | - | 0 | I | |||
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | Common Stock | A | 17,595 | $0.00 | 17,595 | I | J |
| 28 Oct, 2024 | Venture Capital Vi, L.P. Versant | - | - | 17,595 | I |